Si, sur le plan métabolique et du poids corporel, les études restent mitigées sur les effets de la prise régulière ou non du petit-déjeuner, il n’en est pas de même, pour le risque cardiovasculaire. C ...

“I am excited to join AVAVA’s Board of Directors and work with a team committed to advancing the next generation of ...

IXIARO ® is the only JE vaccine approved by the U.S. Food and Drug Administration (FDA), having been developed through a cooperative research and development agreement with the Walter Reed Army ...

Orion Corporation (“Orion”) and Invenra Inc. (“Invenra”), an innovative biotechnology company with proprietary technologies for discovering novel therapeutics, today announced that they have entered ...

Saudi hospitals have made significant strides in the 2025 Brand Finance global ranking of the world’s Top 250 hospitals, with seven Saudi hospitals making the list, including two in the top 100 ...

European patents expand coverage for both essential components of FemBloc for fallopian tube occlusion, resulting in non-surgical permanent contraception ATLANTA, Jan. 30, 2025 (GLOBE NEWSWIRE) -- ...

SAN FRANCISCO, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...

Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, announced today a realignment of its global business operations as part of ...

About Mersana Therapeutics Mersana Therapeutics is a clinical-stage biopharmaceutical company focused on the development of novel antibody-drug conjugates (ADCs) and driven by the knowledge that ...

DECATUR, Ga., Jan. 30, 2025 (GLOBE NEWSWIRE) -- On 30 January 2025, the World Health Organization (WHO) announced that Niger has been verified for eliminating the transmission of onchocerciasis, ...

Liberation Labs has closed a convertible note with $31.5 million in new capital, which, combined with $19 million of insider bridge notes raised during 2024, brings the total raised in its $75 million ...

TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today announced positive momentum in early revenue trends for ...